Help us: Donate
Follow us on:

The SENS AMA Webinar


Come and join Dr. Aubrey de Grey, Dr. Amutha Boominathan, Dr. Matthew O’Connor, and others from the SENS Research Foundation team as they answer your questions about aging research on Friday, October 25th.

Time: 9 am PDT / 12 pm EDT / 5 pm UK

On the day of the event simply join the SENS AMA Webinar or use the link below:

Places on the webinar call are limited to 100 places, but dont worry if you cannot get in because we will also be livestreaming the webinar on our Facebook page and you can ask questions in the chat there.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
  1. October 11, 2019

    When will the next one be?
    I want to ask Dr Aubrey De Grey within each hallmark of ageing which cures are at the forefront, when are they expected to be released to public or in public trials and which if any treatment he believes are worth doing/ taking?

    For the general public to really become advocates I feel there needs to be a simplification; after all the majority that will rally with passion aren’t always going to scientifically aware. If they can be informed in an appropriate way we could gain a powerful movement and momentum.

    • Steve Hill
      October 11, 2019

      You should join the Webinar on the 25th October and ask him as the event has not happened yet :) Agree with you about advocacy, there are a lot of people in the community who lack sufficient scientific knowledge and we really need to help people learn this stuff to become better advocates.

Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.